NERVIANO, Italy, 28 July 2025 — BioNerviano (BioN), a company provides services to the community domiciled in Nerviano Bio-Park, today announced the appointment of Serena Alvino, MBA, CIPP/E, as Chief Executive Officer, effective immediately.
Hugues Dolgos, Pharm.D., Chairman of the BioNerviano Board commented: “On behalf of the Board, I want to express our sincere gratitude to BioN’s outgoing CEO, Mr. Marco Dieci, for his leadership and commitment in helping to assure the quality of the company’s operations. We wish him all the best in his future endeavors.”
Ms. Alvino will continue to serve as Chief Legal Officer and Member of the Board of Directors of Nerviano Medical Sciences Srl (NMS Srl), a clinical-stage biopharmaceutical company and Chief Executive Officer of NerPharMa, a leading Contract Development and Manufacturing Organization (CDMO) specializing in oncology. All three companies are part of the NMS Group.
